Not applicableStudy completedNCT03186430What this trial is testingPreTeenVax EvaluationWho this might be right forHuman Papilloma Virus Emory University 168
Testing effectiveness (Phase 2)Study completedNCT02128126What this trial is testingStudy of the Therapeutic Vaccine (ISA101/ISA101b) to Treat Advanced or Recurrent Cervical CancerWho this might be right forCervical Cancer ISA Pharmaceuticals 93
Not applicableStudy completedNCT01153906What this trial is testingPost-marketing Safety Study of Autoimmune Diseases Following Cervarix® VaccinationWho this might be right forInfections, Papillomavirus GlaxoSmithKline 1,516
Testing effectiveness (Phase 2)Study completedNCT05694728What this trial is testingA Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV VaccineWho this might be right forHuman Papilloma Virus Infection Beijing Health Guard Biotechnology, Inc 780
Post-approval studies (Phase 4)Study completedNCT04982614What this trial is testingHPV Vaccination in HIV Infected and HIV Uninfected Adolescents in EswatiniWho this might be right forHPV InfectionHivHPV Vaccine Columbia University 1,403
Not applicableStudy completedNCT05204030What this trial is testingHashtag HPV: HPV Vaccine Twitter Education ProgramWho this might be right forHuman Papilloma VirusVaccine-Preventable Diseases University of Arkansas, Fayetteville 28
Testing effectiveness (Phase 2)Study completedNCT00316693What this trial is testingHuman Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 VaccineWho this might be right forInfections, Papillomavirus GlaxoSmithKline 1,046
Large-scale testing (Phase 3)Study completedNCT03284866What this trial is testingHPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPVWho this might be right forAIDS-Related Human Papillomavirus InfectionHigh Grade Cervical Squamous Intraepithelial NeoplasiaHIV Infection AIDS Malignancy Consortium 536
Testing effectiveness (Phase 2)Study completedNCT04436133What this trial is testingImmunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)Who this might be right forHPV InfectionHPV-Related Cervical Carcinoma National Vaccine and Serum Institute, China 480
Large-scale testing (Phase 3)Study completedNCT05383625What this trial is testingGardasil Versus Cervarix in the Treatment of WartsWho this might be right forVerruca Viral Zagazig University 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07785843What this trial is testingA Clinical Study of V503 in Chinese Females Who Have Previously Received a Bivalent Human Papillomavirus (HPV) Vaccine (V503-108)Who this might be right forPapillomavirus Infections Merck Sharp & Dohme LLC 930
Testing effectiveness (Phase 2)Study completedNCT01209325What this trial is testingVaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With MalesWho this might be right forAnal CancerNonneoplastic ConditionPenile Cancer+1 more AIDS Malignancy Consortium 149
Large-scale testing (Phase 3)Study completedNCT00157950What this trial is testingHuman Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)Who this might be right forPapillomavirus Infections Merck Sharp & Dohme LLC 176
Large-scale testing (Phase 3)Study completedNCT01381575What this trial is testingEvaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old GirlsWho this might be right forInfections, Papillomavirus GlaxoSmithKline 1,447
Testing effectiveness (Phase 2)Active Not RecruitingNCT03519464What this trial is testingImmunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell LymphocytopeniaWho this might be right forIdiopathic CD4 T Cell Lymphocytopenia National Institute of Allergy and Infectious Diseases (NIAID) 54
Post-approval studies (Phase 4)UnknownNCT03350698What this trial is testingOccupational Exposure to Human Papilloma Virus (HPV) and Prophylactic VaccinationWho this might be right forPapillomavirus Vaccines Eastern Virginia Medical School 100
Post-approval studies (Phase 4)Active Not RecruitingNCT03391921What this trial is testingVaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study)Who this might be right forHPV - Anogenital Human Papilloma Virus InfectionHIV Infections Centre Hospitalier Universitaire Saint Pierre 170
Post-approval studies (Phase 4)Study completedNCT02624349What this trial is testingImmunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant RecipientsWho this might be right forLate Complication From Kidney TransplantComplication of Transplanted LiverHuman Papillomavirus-Related Carcinoma The Hospital for Sick Children 37
Large-scale testing (Phase 3)Study completedNCT05119855What this trial is testingSafety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)Who this might be right forPapillomavirus InfectionsCoronavirus Disease (COVID-19) Merck Sharp & Dohme LLC 165
Not applicableStudy completedNCT00715234What this trial is testingEvaluation of Vaccination Reminder/Recall Systems for Adolescent PatientsWho this might be right forHuman Papilloma Virus (HPV)Tetanus-diphtheria-acellular Pertussis (Tdap)Meningococcal Infection+1 more University of Colorado, Denver 4,807